← All companies

TCRX

TScan Therapeutics, Inc.

TCRX Nasdaq Biological Products, (No Diagnostic Substances) EDGAR ↗

$0.72

-0.03 -4.37%

Key statistics

from XBRL data in SEC filings

Market cap

$93.9M

Revenue (TTM)

$9.14M

Net income (TTM)

-$124M

EPS (TTM)

$-0.96

P/E ratio

—

Dividend yield

—

Free cash flow

-$140M

Cash

$128M

Total assets

$202M

Gross margin

—

52-week range

$0.72 – $2.57

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Regulation FD disclosure; Other events Jun 22, 2026 8-K Amended charter or bylaws; Shareholder vote results May 22, 2026 10-Q Quarter ended 2026-03-31 May 6, 2026 8-K Results of operations (earnings release) May 6, 2026 8-K Director or officer change Apr 2, 2026 10-K Fiscal year ended 2025-12-31 Mar 4, 2026 8-K Results of operations (earnings release) Mar 4, 2026 8-K Regulation FD disclosure Jan 12, 2026 8-K Director or officer change Nov 26, 2025 10-Q Quarter ended 2025-09-30 Nov 12, 2025 8-K Results of operations (earnings release) Nov 12, 2025 8-K Exit or disposal costs; Regulation FD disclosure; Other events Nov 3, 2025 8-K Regulation FD disclosure Sep 9, 2025 8-K Director or officer change Aug 20, 2025 10-Q Quarter ended 2025-06-30 Aug 12, 2025 8-K Results of operations (earnings release) Aug 12, 2025 8-K Shareholder vote results Jul 2, 2025 10-Q Quarter ended 2025-03-31 May 6, 2025 8-K Results of operations (earnings release) May 6, 2025 10-K Fiscal year ended 2024-12-31 Mar 5, 2025 8-K Results of operations (earnings release) Mar 5, 2025 8-K Entered a material agreement; Other events Dec 26, 2024 8-K Entered a material agreement; Terminated a material agreement; Took on a direct financial obligation; Regulation FD disclosure Dec 23, 2024 8-K Regulation FD disclosure; Other events Dec 10, 2024 8-K Unregistered sale of equity Nov 21, 2024 10-Q Quarter ended 2024-09-30 Nov 12, 2024 8-K Results of operations (earnings release) Nov 12, 2024 8-K Entered a material agreement Nov 1, 2024 10-Q Quarter ended 2024-06-30 Aug 12, 2024 8-K Results of operations (earnings release) Aug 12, 2024 8-K Director or officer change; Shareholder vote results Jun 14, 2024 10-Q Quarter ended 2024-03-31 May 13, 2024 8-K Results of operations (earnings release) May 13, 2024 8-K Entered a material agreement; Results of operations (earnings release); Other events Apr 17, 2024 8-K Regulation FD disclosure; Other events Apr 16, 2024 10-K/A Fiscal year ended 2023-12-31 Apr 10, 2024 8-K Other events Apr 8, 2024 10-K Fiscal year ended 2023-12-31 Mar 6, 2024 8-K Results of operations (earnings release) Mar 6, 2024 8-K Director or officer change Jan 29, 2024